Articles

Clinical research

10.4244/EIJ-D-19-00333 Dec 20, 2019
Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation
Badhwar V, Sorajja P, Duncan A, Thourani V, Schaefer U, Grayburn P, Dumonteil N, Babaliaros V, Garatti A, Lessick J, Chuang M, Blanke P, Muller DW
free

Will this trial change my practice ?

10.4244/EIJ-D-19-00587 Dec 20, 2019
Will the Evolut Low Risk trial change my practice?
O'Sullivan C, Reardon MJ, Søndergaard L, Treede H, Jüni P, Windecker S
free

Will this trial change my practice ?

10.4244/EIJ-D-19-00847 Dec 20, 2019
Will the PARTNER 3 Low Risk Trial change my practice?
McConkey H, Modine T, Latib A, Jüni P, Windecker S, Leon MB
free

Clinical research

10.4244/EIJ-D-19-00206 Dec 20, 2019
First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial
Moreu J, Moreno-Gómez R, Perez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat-Santos I
free

Clinical research

10.4244/EIJ-D-19-00202 Dec 20, 2019
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys PW, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg G, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F
free

Clinical research

10.4244/EIJ-D-18-01073 Dec 20, 2019
Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial
Kuroda K, Otake H, Shinohara M, Kuroda M, Tsuda S, Toba T, Nagano Y, Toh R, Ishida T, Shinke T, Hirata K
free

Clinical research

10.4244/EIJ-D-19-00187 Dec 20, 2019
Incidence and predictors of stent thrombosis after endovascular revascularisation of the superficial femoral artery
Bradaric C, Koppara T, Müller A, Haller B, Ott I, Cassese S, Fusaro M, Kastrati A, Laugwitz K, Ibrahim T
free

10.4244/EIJV15I11A174 Dec 6, 2019
Antiplatelet strategies for complex PCI
Capodanno D
free

10.4244/EIJV15I11A175 Dec 6, 2019
Short DAPT duration after ACS – not for the faint of heart
Mihatov N, Yeh R
free

10.4244/EIJV15I11A176 Dec 6, 2019
Are all DES equal at 10-year follow-up?
Bär S, Windecker S, Räber L
free

10.4244/EIJV15I11A177 Dec 6, 2019
FFR for CABG: not ready for prime time
Gaudino M, Di Franco A, Taggart D
free

10.4244/EIJV15I11A179 Dec 6, 2019
Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION?
Galper B, Baron S, Cohen D
free

10.4244/EIJV15I11A180 Dec 6, 2019
The challenge of innovation for the (interventional?) cardiology world
Lotan C
free

Clinical research

10.4244/EIJ-D-18-00847 Dec 6, 2019
Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients at lower surgical risk: results from the NOTION trial
Geisler B, Jørgensen T, Thyregod H, Pietzsch J, Søndergaard L
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved